HomeTagsCetuximab

Cetuximab

Biotechnology

Jacobio Pharma to Collaborate with Merck on Clinical Trial of JAB-21822

PR Newswire - October 13, 2022

Jacobio announced it has entered into a clinical trial collaboration agreement with Merck on clinical study of combination therapy between Jacobio's KRAS G12C inhibitor...

Biotechnology

Jacobio JAB-21822 in Combination with Cetuximab Completes First Dose of Colorectal Cancer Patient in China

PR Newswire - February 25, 2022

Jacobio Pharmaceuticals announced that its KRAS G12C inhibitor JAB-21822 completed the first patient dosing in combination therapy with Cetuximab at Peking University Cancer Hospital...